|
UBE2T expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.74040004630172E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.06750000000855E-05 |
| Normal-vs-Stage2 |
2.037200E-03 |
| Normal-vs-Stage3 |
3.55560000000477E-05 |
| Normal-vs-Stage4 |
9.97580000050569E-07 |
| Stage1-vs-Stage2 |
3.631200E-01 |
| Stage1-vs-Stage3 |
4.155600E-02 |
| Stage1-vs-Stage4 |
1.991370E-04 |
| Stage2-vs-Stage3 |
4.221600E-01 |
| Stage2-vs-Stage4 |
2.341900E-03 |
| Stage3-vs-Stage4 |
9.379700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.79339998407357E-09 |
| Normal-vs-AfricanAmerican |
2.677800E-03 |
| Normal-vs-Asian |
1.836240E-01 |
| Caucasian-vs-AfricanAmerican |
5.106100E-02 |
| Caucasian-vs-Asian |
3.914200E-01 |
| AfricanAmerican-vs-Asian |
3.797400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.25310003776747E-09 |
| Normal-vs-Female |
2.02699999996003E-06 |
| Male-vs-Female |
9.845900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.506080E-02 |
| Normal-vs-Age(41-60Yrs) |
1.64069999997185E-06 |
| Normal-vs-Age(61-80Yrs) |
8.09469999918377E-08 |
| Normal-vs-Age(81-100Yrs) |
5.899000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.817600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.243600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.520600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.178400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.526200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.247000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.616200E-01 |
| Normal-vs-Grade 2 |
1.629470E-04 |
| Normal-vs-Grade 3 |
4.7356000010268E-08 |
| Normal-vs-Grade 4 |
3.28890000000914E-06 |
| Grade 1-vs-Grade 2 |
4.830200E-01 |
| Grade 1-vs-Grade 3 |
1.739930E-02 |
| Grade 1-vs-Grade 4 |
1.368840E-04 |
| Grade 2-vs-Grade 3 |
1.921480E-03 |
| Grade 2-vs-Grade 4 |
2.003600E-04 |
| Grade 3-vs-Grade 4 |
3.136700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.664100E-03 |
| Normal-vs-ccB subtype |
8.42799999789534E-08 |
| ccA subtype-vs-ccB subtype |
3.82230000000039E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.45930000037009E-07 |
| Normal-vs-N1 |
1.700320E-03 |
| N0-vs-N1 |
1.089900E-02 |
|
|
